Skip to main content

Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US

Written by Customer Service on . Posted in Public Companies.

Biatain Silicone Fit

Coloplast's Biatain Silicone Fit is developed for pressure injury prevention and wound management.
Coloplast’s Biatain Silicone Fit is developed for pressure injury prevention and wound management.

The company aims to expand its position within advanced wound care by introducing a new silicone foam that will benefit both healthcare professionals and patients.

  • “We are now introducing new innovation to the US market, aiming to grow our presence within the foam dressings segment. We have a great product in our hands, and we have invested significantly in our sales organization to reach the full potential of this launch. I am really excited to get started,” says Kimberly Ditter, Vice President of Wound & Skin Care, North America.

Changing demographics and an aging population are leading to a higher demand for healthcare services, putting significant strain on healthcare systems. In the US, chronic wounds are reported to affect 10.5 million patients annually1, while 2.5 million patients develop a pressure injury in acute care facilities each year2. Therefore, it is critical for healthcare providers to choose products that simplify their workflows and deliver the best possible care for their patients.

  • “Choosing the right dressing for wound treatment or pressure injury prevention should be simple and easy and give the patient a soft, secure and comfortable fit. Biatain Silicone Fit offers exactly that. It fits to the body, and it fits to the wound,” says Kimberly Ditter.

Fits to the body and fits to the wound
Biatain Silicone Fit with 3DFit Technology is designed for both pressure injury prevention and wound management. It stays securely in place during patient movement, fitting to body creases and allowing easy skin inspection as part of pressure injury prevention protocols3. It also matches the shape and depth of the wound bed up to 2 cm deep4, lowering the risk of infection and maceration for optimal wound healing conditions.

Biatain Silicone Fit comes in 12 different sizes and shapes to suit the facility’s needs. All sizes and shapes are developed and indicated for both pressure injury prevention and wound treatment to accommodate multiple purposes and a reduced number of SKUs.

Biatain Silicone Fit is available in the US as of January 2024.

Expanding Wound Care in the US
The global advanced wound dressings market is estimated at DKK 26-28 billion, with an annual estimated growth rate of 2-4%. Around 25-30% of the market is derived from the US, where products are typically used in the hospital setting.  

  1. Sen CK. Human Wound and Its Burden: Updated 2022 Compendium of Estimates. Adv Wound Care (New Rochelle). 2023 Dec;12(12):657-670. (LINK)
  2. Padula WV, Delarmente BA. The national cost of hospital-acquired pressure injuries in the United States. Int Wound J. 2019 Jun;16(3):634-640. (LINK)
  3. Coloplast data on file, 2022. Based on simulated use.
  4. Coloplast data on file 2023. Fit to the wound bed may vary across product design.


Contacts
Peter Mønster
Sr. Media Relations Manager, Global Communications
+45 4911 2623
dkpete@coloplast.com

Aleksandra Dimovska
Sr. Director, Investor Relations
+45 4911 2458

dkadim@coloplast.com

Attachments

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.